1-20 of 25
Mark Robson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 1928: Prediction of neoadjuvant treatment outcomes with multimodal data integration in breast cancer

Pegah Khosravi, Elizabeth J. Sutton, Justin Jee, Timothy Dalfonso, Christopher J. Fong, Doori Rose, Edaise M. Da Silva, Armaan Kohli, David Joon Ho, Mehnaj S. Ahmed, Danny Martinez, Anika Begum, Elizabeth Zakszewski, Andrew Aukerman, Yanis Tazi, Katja Pinker-Domenig, Sarah Eskreis-Winkler, Atif J. Khan, Edi Brogi, Elizabeth Morris, Sarat Chandarlapaty, George Plitas, Simon Powell, Monica Morrow, Larry Norton, Jianjiong Gao, Mark Robson, Hong Zhang, Sohrab Shah, Pedram Razavi, MSK-MIND Consortium
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 1928.
DOI: https://doi.org/10.1158/1538-7445.AM2022-1928
Published: 15 June 2022
View article
Journal Articles

Abstract OT2-23-01: A Phase 1b/2a, open-label platform study to evaluate mirdametinib in combination with fulvestrant in ER+ metastatic breast cancers harboring MAPK-activating mutations

Ezra Y. Rosen, Payal Patel, Nenad Sarapa, Badreddin Edris, Alexia Iasonos, Komal Jhaveri, Pedram Razavi, Mark Robson, Alexander Drilon, Michael F. Berger, David B. Solit, Sarat Chandarlapaty
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): OT2-23-01.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-OT2-23-01
Published: 15 February 2022
View article
Journal Articles

Abstract OT2-18-01: Harnessing olaparib, palbociclib, and endocrine therapy (HOPE): Phase I/II trial of olaparib, palbociclib and fulvestrant in patients with BRCA1/2-associated, hormone receptor-positive, HER2-negative metastatic breast cancer

Alexandra Torres, Carey Kokkonen, Mary Oladeji, Kurt D'Andrea, Rosemarie Mick, Vivek Narayan, Michael Mallamaci, Gayle Ewing, Hayley Knollman, Nadine M. Tung, Mark Robson, Katherine L. Nathanson, Susan Domchek, Payal D. Shah
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): OT2-18-01.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-OT2-18-01
Published: 15 February 2022
View article
Journal Articles

Abstract P1-09-05: Baseline dietary patterns among women with newly diagnosed early-stage breast cancer enrolled in the Optimal Living Program

Sherry Shen, Johnny Allsop, Erica Salehi, Cara Anselmo, Stacie Corcoran, Jill Clayton, Andrea Smith, Melissa Emerzian, Mark Robson, Neil Iyengar
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P1-09-05.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-P1-09-05
Published: 15 February 2022
View article
Journal Articles

Abstract P1-18-18: Real-world natural history data among patients with PIK3CA-mutant and PIK3CA-wild-type advanced breast cancer

Pedram Razavi, Rohan C Parikh, Barbara Acevedo, Abigail Hitchens, Mehnaj Ahmed, Anton Safonov, Emanuela Ferraro, Komal Jhaveri, Michelle Sidel, Stacey Simmons, Mark Robson, Sarat Chandarlapaty, Sanjeev Balu
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P1-18-18.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-P1-18-18
Published: 15 February 2022
View article
Journal Articles

Abstract P2-11-21: Integration of an ancestrally unbiased polygenic risk score with the Tyrer-Cuzick breast cancer risk model

Elisha Hughes, Ryan Bernhisel, Holly Pederson, Braden Probst, Timothy Simmons, Susanne Wagner, Thaddeus Judkins, Eric Rosenthal, Benjamin Roa, Susan M. Domchek, Charis Eng, Judy Garber, Monique Gary, Ora K. Gordon, Jennifer Klemp, Semanti Mukherjee, Kenneth Offit, Funmi Olopade, Joseph Vijai, Jeffrey N. Weitzel, Pat Whitworth, Lamis Yehia, Allison Kurian, Mark Robson, Thomas P. Slavin, Alexander Gutin, Jerry S. Lanchbury
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P2-11-21.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-P2-11-21
Published: 15 February 2022
View article
Journal Articles

Abstract P2-13-19: Statin modulation of antibody drug conjugate activity in breast cancer models and patients

Joshua Z Drago, Patricia R Pereira, Anton Safonov, Antonio Marra, Yi Rao, Bo Liu, Mehnaj Ahmed, Shanu Modi, Jorge Reis-Filho, Mark Robson, Filippo Montemurro, Pedram Razavi, Jason S Lewis, Sarat Chandarlapaty
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P2-13-19.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-P2-13-19
Published: 15 February 2022
View article
Journal Articles

Abstract GS4-08: Comprehensive genomic profiling of patients with breast cancer identifies germline-somatic interactions mediating therapy resistance

Anton Safonov, Chai Bandlamudi, Paulino Tallón de Lara, Emanuela Ferraro, Fatemeh Derakhshan, Marie Will, Mark Donoghue, Pier Selenica, Joshua Drago, Ezra Rosen, Carlos dos Anjos, Elaine Walsh, Elizabeth A Comen, Mehnaj Ahmed, Barbara Acevedo, Ahmet Zehir, Michael F Berger, David Solit, Larry Norton, Ronglai Shen, Zsofia Stadler, Simon Powell, Jorge S Reis-Filho, Sarat Chandarlapaty, Mark Robson, Pedram Razavi
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): GS4-08.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-GS4-08
Published: 15 February 2022
View article
Journal Articles

Abstract PS11-10: A Phase 1b/2 Study of the BET inhibitor ZEN003694 in combination with talazoparib for treatment of patients with TNBC without gBRCA1/2 mutations

Philippe Aftimos, Mafalda Oliveira, Kevin Punie, Valentina Boni, Erika Hamilton, Ayca Gucalp, Payal Shah, Lida Mina, Priyanka Sharma, Lisa Bauman, Eric Campeau, Sarah Attwell, Margo Snyder, Karen Norek, Akos Czibere, Yanke Yu, Michael H Silverman, Sanjay Lakhotia, Susan Domchek, Jennifer Litton, Mark Robson
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PS11-10.
DOI: https://doi.org/10.1158/1538-7445.SABCS20-PS11-10
Published: 15 February 2021
View article
Journal Articles

Abstract PS9-04: The optimal living and survivorship program: Piloting a novel cancer survivorship care model

Stacie Corcoran, John Russell, Jill Clayton, Andrea Smith, Kate Keenan, Mark Robson, Neil Iyengar
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PS9-04.
DOI: https://doi.org/10.1158/1538-7445.SABCS20-PS9-04
Published: 15 February 2021
View article
Journal Articles

Abstract PD4-03: OlympiAD extended follow-up for overall survival and safety: Olaparib versus chemotherapy treatment of physician’s choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer

Mark Robson, Seock-Ah Im, Elżbieta Senkus, Binghe Xu, Susan Domchek, Norikazu Masuda, Suzette Delaloge, Wei Li, Nadine Tung, Anne Armstrong, Wendy Bannister, Carsten Goessl, Allison Allen, Pierfranco Conte
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): PD4-03.
DOI: https://doi.org/10.1158/1538-7445.SABCS19-PD4-03
Published: 15 February 2020
View article
Journal Articles

Abstract P5-14-02: Yoga for chemotherapy-induced peripheral neuropathy and fall risk in breast and gynecological cancer survivors: A pilot study

Ting Bao, Madeline Hooper, Raymond Baser, Patricia Chen, Lauren Piulson, Clare Patterson, Tina Paul, Connie Chen, Qing Li, Katherine Panageas, Iris Zhi, Victoria Blinder, Mark Robson, Andrew Seidman, Jun Mao
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P5-14-02.
DOI: https://doi.org/10.1158/1538-7445.SABCS19-P5-14-02
Published: 15 February 2020
View article
Journal Articles

Abstract P6-08-25: Surgical decision making and clinical outcomes in breast cancer (BC) patients (pts) with germline alterations in moderate risk BC susceptibility genes (CHEK2, PALB2 and ATM)

Carlos Henrique dos Anjos, Kimberly Amoros, Melissa Pilewskie, Lior Braunstein, Mark Robson
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P6-08-25.
DOI: https://doi.org/10.1158/1538-7445.SABCS19-P6-08-25
Published: 15 February 2020
View article
Journal Articles

Abstract P5-12-09: Patient-reported outcomes (PROs) during one year of adjuvant enzalutamide for the treatment of early stage androgen receptor positive (AR+) triple negative breast cancer

Tiffany A Traina, Lee W Jones, Victoria Blinder, Jessica Scott, Leigh Ann Boyle, Artavazd Arumov, Tina Alano, Sujata Patil, Patricia DeFusco, Nicholas Lamparella, Mark Robson, Ayca Gucalp
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P5-12-09.
DOI: https://doi.org/10.1158/1538-7445.SABCS19-P5-12-09
Published: 15 February 2020
View article
Journal Articles

Abstract P6-08-07: Polygenic breast cancer risk modification in carriers of high and intermediate risk gene mutations

Shannon Gallagher, Elisha Hughes, Susanne Wagner, Placede Tshiaba, Eric Rosenthal, Benjamin B. Roa, Allison Kurian, Susan Domchek, Judy Garber, Johnathan M. Lancaster, Jeffrey Weitzel, Alexander Gutin, Jerry S. Lanchbury, Mark Robson
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P6-08-07.
DOI: https://doi.org/10.1158/1538-7445.SABCS19-P6-08-07
Published: 15 February 2020
View article
Journal Articles

Abstract OT2-08-02: Capivasertib and paclitaxel in first-line treatment of patients with metastatic triple-negative breast cancer: A phase III trial (CAPItello-290)

Peter Schmid, Javier Cortes, Mark Robson, Hiroji Iwata, Roberto Hegg, Sunil Verma, Marina Nechaeva, Binghe Xu, Vincent Haddad, Esteban Rodrigo Imedio, Gaia Schiavon, Andrew Foxley, Yeon Hee Park
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): OT2-08-02.
DOI: https://doi.org/10.1158/1538-7445.SABCS19-OT2-08-02
Published: 15 February 2020
View article
Journal Articles

Abstract P2-16-10: Disease free survival rate with dose dense Doxorubicin and Cyclophosphamide followed by weekly Paclitaxel with Trastuzumab and Pertuzumab (ddACTHP) in patients with HER2-positive early stage breast cancer: A single institution experience

Jasmeet C Singh, Sujata Patil, Larry Norton, Mark Robson, Chau Dang
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P2-16-10.
DOI: https://doi.org/10.1158/1538-7445.SABCS19-P2-16-10
Published: 15 February 2020
View article
Journal Articles

Abstract 1572: Inherited truncating RAD52 variant discovered using integrated germline- somatic analysis predicts clinical outcome in patients with lung cancers

Semanti Mukherjee, Preethi Srinivasan, Chaitanya Bandlamudi, Matthew D. Hellmann, Vignesh Ravichandran, Myvizhi Esai Selvan, Yelena Kemel, Diana Mandelker, Marjorie Zauderer, Michael Walsh, Ahmet Zehir, Maria I Carlo, Karen Cadoo, Steven M Lipkin, Marc Ladanyi, David Solit, Mark Robson, Liying Zhang, David Jones, Charles Rudin, Robert Klein, Zsofia Stadler, Joseph Vijai, Zeynep Gumus, Barry Taylor, Michael Berger, Kenneth Kenneth
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 1572.
DOI: https://doi.org/10.1158/1538-7445.AM2019-1572
Published: 01 July 2019
View article
Journal Articles

Abstract 4158: Dissecting the role of zygosity and lineage in Lynch Syndrome-associated microsatellite Instability

Preethi Srinivasan, Chaitanya Bandlamudi, Jinru Shia, Alicia S. Latham, Philip Jonsson, Alexander Penson, Sumit Middha, Jackie Hechtman, Ahmet Zehir, Allison Richards, Shweta Chawan, Yelena Kemel, Diana Mandelker, Liying Zhang, David Hyman, Marc Ladanyi, Mark Robson, Kenneth Offit, David Solit, Barry Taylor, Michael Berger, Zsofia Stadler
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 4158.
DOI: https://doi.org/10.1158/1538-7445.AM2019-4158
Published: 01 July 2019
View article
Journal Articles

Abstract 4280: FH (rs367543046, chr1:241661227 A/ATTT) heterozygous carrier status does not confer risk to hereditary leiomyomatosis and renal cell cancer (HLRCC) and prostate cancer

Michael F. Walsh, Diana Mandelker, Joseph Vijai, David Musheyev, Jennifer Kennedy, Zsofia Stadler, Yelena Kemel, Sabine Topka, Karen Cadoo, Maria Carlo, Marc Ladanyi, Mark Robson, Kenneth Offit, Liying Zhang
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 4280.
DOI: https://doi.org/10.1158/1538-7445.AM2017-4280
Published: 01 July 2017
View article